Beach D H, Chen F, Cushion M T, Macomber R S, Krudy G A, Wyder M A, Kaneshiro E S
Department of Microbiology and Immunology, State University of New York Health Science Center at Syracuse 13210, USA.
Antimicrob Agents Chemother. 1997 Jan;41(1):162-8. doi: 10.1128/AAC.41.1.162.
Several pathogenic fungi and protozoa are known to have sterols distinct from those of their mammalian hosts. Of particular interest as targets for drug development are the biosyntheses of the sterols of important parasites such as the kinetoplastid flagellates and the AIDS-associated opportunistic protist Pneumocystis carinii. These pathogens synthesize sterols with an alkyl group at C-24, and some have a double bond at C-22 of the side chain. Humans and other mammalian hosts are incapable of C-24 alkylation and C-22 desaturation. In the present study, three steroidal compounds with side chains substituted by phosphonyl-linked groups were synthesized and tested for their effects on Leishmania donovani and L. mexicana mexicana culture growth. The compounds inhibited organism proliferation at concentrations in micrograms per milliliter. The most potent inhibitors of this group of compounds were characterized by two ethyl groups at the phosphate function. Leishmania organisms treated with 17-[2-(diethylphosphonato) ethylidienyl]3-methoxy-19-norpregna-1,3,5-triene exhibited reduced growth after transfer into inhibitor-free medium. Because there are currently no axenic methods available for the continuous subcultivation of P. carinii, the effects of these drugs on this organism were evaluated by two alternative screening methods. The same two diethyl phosphonosteroid compounds that inhibited Leishmania proliferation were also the most active against P. carinii as determined by the potent effect they had on reducing cellular ATP content. Cystic as well as trophic forms responded to the drug treatments, as evaluated by a dual fluorescent staining live-dead assay. Other modifications of steroidal phosphonates may lead to the development of related drugs with increased activity and specificity for the pathogens.
已知几种致病真菌和原生动物含有与它们的哺乳动物宿主不同的固醇。作为药物开发靶点,特别受关注的是重要寄生虫的固醇生物合成,如动基体鞭毛虫和与艾滋病相关的机会性原生生物卡氏肺孢子虫。这些病原体合成的固醇在C-24位有一个烷基,有些在侧链的C-22位有一个双键。人类和其他哺乳动物宿主无法进行C-24烷基化和C-22去饱和。在本研究中,合成了三种侧链被膦酰基连接基团取代的甾体化合物,并测试了它们对杜氏利什曼原虫和墨西哥利什曼原虫墨西哥亚种培养生长的影响。这些化合物在微克每毫升的浓度下抑制生物体增殖。这组化合物中最有效的抑制剂的特征是在磷酸官能团处有两个乙基。用17-[2-(二乙基膦酰基)亚乙基]3-甲氧基-19-去甲孕甾-1,3,5-三烯处理的利什曼原虫生物体在转移到无抑制剂培养基后生长受到抑制。由于目前没有可用于卡氏肺孢子虫连续传代培养的无菌方法,因此通过两种替代筛选方法评估了这些药物对该生物体的影响。通过对细胞ATP含量的显著降低作用确定,同样两种抑制利什曼原虫增殖的二乙基膦酰甾体化合物对卡氏肺孢子虫也最具活性。通过双荧光染色活死测定法评估,囊肿和营养体形式均对药物治疗有反应。甾体膦酸盐的其他修饰可能会导致开发出对病原体活性和特异性更高的相关药物。